Connor, Clark & Lunn Investment Management (CC&L)
ZNTL icon

Connor, Clark & Lunn Investment Management (CC&L)’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Buy
792,001
+4,946
+0.6% +$12.8K ﹤0.01% 982
2025
Q4 		$1.06M Buy
787,055
+406,233
+107% +$591K ﹤0.01% 1111
2025
Q3 		$575K Buy
380,822
+65,977
+21% +$98.9K ﹤0.01% 1219
2025
Q2 		$365K Sell
314,845
-46,391
-13% -$61.2K ﹤0.01% 1320
2025
Q1 		$574K Buy
361,236
+16,197
+5% +$34.9K ﹤0.01% 1104
2024
Q4 		$1.05M Buy
345,039
+115,901
+51% +$380K ﹤0.01% 917
2024
Q3 		$843K Buy
229,138
+127,868
+126% +$465K ﹤0.01% 935
2024
Q2 		$414K Buy
101,270
+81,799
+420% +$914K ﹤0.01% 1097
2024
Q1 		$307K Buy
+19,471
New +$268K ﹤0.01% 1256

Other funds holding ZNTL

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $250M AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return